Back to today’s briefing

Story perspectives

FTC Accuses UnitedHealth of 7,700% Drug Price Inflation

1/18/2025

50 3

Summary

Story summary

UnitedHealth and two other pharmacy benefit managers have come under fire from the Federal Trade Commission (FTC) for inflating prices of essential medications by a staggering 7,700%, raking in $7.3 billion in profits from 2017 to 2022. This alarming report underscores the urgent need for policy reform, though the companies vehemently contest the allegations.

1 of 1

Story summary

UnitedHealth and two other pharmacy benefit managers have come under fire from the Federal Trade Commission (FTC) for inflating prices of essential medications by a staggering 7,700%, raking in $7.3 billion in profits from 2017 to 2022. This alarming report underscores the urgent need for policy reform, though the companies vehemently contest the allegations.